MILLENNIUM MANAGEMENT LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 2 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$2
-100.0%
118,500
+3.5%
0.00%–
Q3 2022$10,000
+11.1%
114,5000.0%0.00%–
Q2 2022$9,000–114,500–0.00%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2023
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 9,800$108,0540.10%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders